Sequential re-rating: management describes the same offering landing bigger the second and third time around
The model's full reasoning — Q1 2024 call → NOWe need to determine if management describes successive engagements of the same kind coming in at progressively larger size. The transcript mentions a new contract with Container Maintenance Corporation, which is expected to be approximately $6 million over five years. Scott Shaw says: "What is different about this contract is that none of our students are involved. Instead, we are leveraging our curriculum and training capabilities to upskill their employees at their facilities. While we have enormous opportunities with our campus focused growth strategies, we believe that we have additional growth opportunities by providing workforce trending to companies across the country, whether we have a campus in their area or not. We are currently pursuing additional contracts with other employers." This describes a new type of business (workforce training for employers) that is not the same as their core campus-based education. It's a new offering, not a larger instance of the same kind. Also, they say "we are currently pursuing additional contracts" but no indication that these are larger than previous ones. There's no comparison against their own past for this type of business. The $6 million contract is described as "strategically critical" but not as part of an upward drift in deal size. It's a new venture. So no. Also, they mention program replication, new campuses, etc., but that's about expansion, not about individual deals getting bigger. The question asks about successive engagements of the same kind coming in at progressively larger size. The only specific deal mentioned is the Container Maintenance Corporation, but it's a new type of business, not a larger version of existing business. No comparison to past deals of that type. So answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASO | Academy Sports and Outdoors, Inc. | Q1 2024 | 2024-06-11 | C+ |
| AKYA | Akoya Biosciences, Inc. | Q2 2023 | 2023-08-07 | C+ |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| SGRY | Surgery Partners, Inc. | Q2 2022 | 2022-08-02 | B+ |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
AKYA · Q2 2023 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing a clear pattern of escalating project sizes in the translational/clinical space. Brian notes a migration from exploratory studies (reasonable size) to larger retrospective studies and even larger retrospective-prospective ongoing clinical studies, with projects moving "further and further downstream.
ASAN · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES Management describes exactly this pattern. Dustin notes the company is “closing larger deals and expanding seats across departments and geographies quickly in large organizations,” and that the growth in the >$50k cohort “reflected an acceleration in our largest enterprise customers.
SGRY · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing exactly this pattern for physician recruiting cohorts. Wayne notes that the 2022 cohorts are “no exception to this trend, bringing more cases with a higher overall net revenue per case than our 2021 cohorts did in the same period last year.